| BGF 320/14.4/10 µg | GFF 14.4/10 µg | BFF 320/10 µg |
---|---|---|---|
EOS 100 to < 300 cells/mm3 |  |  |  |
Without exacerbation history in the preceding 12 months | N = 308 | N = 307 | N = 147 |
 Patients with exacerbations, n (%) | 45 (14.6) | 76 (24.8) | 24 (16.3) |
 Eventsa | 50 | 99 | 25 |
 Total time at risk, years | 131.31 | 126.63 | 61.30 |
 Adjusted COPD exacerbation rate (SE)b | 0.35 (0.06) | 0.79 (0.10) | 0.38 (0.09) |
With exacerbation history in the preceding 12 months | N = 102 | N = 92 | N = 45 |
 Patients with exacerbations, n (%) | 22 (12.6) | 32 (34.8) | 16 (35.6) |
 Eventsa | 31 | 41 | 19 |
 Total time at risk, years | 43.51 | 37.14 | 17.61 |
 Adjusted COPD exacerbation rate (SE)b | 0.64 (0.14) | 1.13 (0.23) | 1.04 (0.31) |
Moderate COPD | N = 201 | N = 204 | N = 90 |
 Patients with exacerbations, n (%) | 25 (12.4) | 44 (21.6) | 17 (18.9) |
 Eventsa | 29 | 50 | 20 |
 Total time at risk, years | 86.54 | 86.71 | 36.38 |
 Adjusted COPD exacerbation rate (SE)b | 0.29 (0.06) | 0.55 (0.09) | 0.51 (0.13) |
Severe COPD | N = 182 | N = 163 | N = 89 |
 Patients with exacerbations, n (%) | 37 (20.3) | 52 (31.9) | 22 (24.7) |
 Eventsa | 47 | 66 | 23 |
 Total time at risk, years | 77.54 | 65.04 | 37.12 |
 Adjusted COPD exacerbation rate (SE)b | 0.55 (0.10) | 1.10 (0.18) | 0.62 (0.16) |
Very severe COPD | N = 26 | N = 32 | N = 12 |
 Patients with exacerbations, n (%) | 5 (19.2) | 12 (37.5) | 1 (8.3) |
 Eventsa | 5 | 24 | 1 |
 Total time at risk, years | 10.27 | 12.01 | 4.94 |
 Adjusted COPD exacerbation rate (SE)b | 0.43 (0.24) | 1.47 (0.50) | 0.15 (0.17) |
EOS ≥ 100 cells/mm3 |  |  |  |
Without exacerbation history in the preceding 12 months | N = 363 | N = 368 | N = 179 |
 Patients with exacerbations, n (%) | 51 (14.0) | 90 (24.5) | 27 (15.1) |
 Eventsa | 60 | 128 | 28 |
 Total time at risk, years | 155.06 | 149.63 | 74.46 |
 Adjusted COPD exacerbation rate (SE)b | 0.36 (0.057) | 0.93 (0.117) | 0.35 (0.081) |
With exacerbation history in the preceding 12 months | N = 119 | N = 116 | N = 53 |
 Patients with exacerbations, n (%) | 27 (22.7) | 43 (37.1) | 18 (34.0) |
 Eventsa | 37 | 64 | 22 |
 Total time at risk, years | 50.55 | 46.12 | 21.25 |
 Adjusted COPD exacerbation rate (SE)b | 0.69 (0.148) | 1.53 (0.278) | 1.07 (0.310) |
Moderate COPD | N = 245 | N = 250 | N = 113 |
 Patients with exacerbations, n (%) | 29 (11.8) | 62 (24.8) | 19 (16.8) |
 Eventsa | 34 | 90 | 23 |
 Total time at risk, years | 105.78 | 103.10 | 46.29 |
 Adjusted COPD exacerbation rate (SE)b | 0.28 (0.06) | 0.92 (0.14) | 0.45 (0.12) |
Severe COPD | N = 205 | N = 198 | N = 104 |
 Patients with exacerbations, n (%) | 43 (21.0) | 59 (29.8) | 24 (23.1) |
 Eventsa | 57 | 78 | 25 |
 Total time at risk, years | 87.15 | 78.77 | 43.16 |
 Adjusted COPD exacerbation rate (SE)b | 0.60 (0.10) | 1.05 (0.16) | 0.61 (0.15) |
Very severe COPD | N = 30 | N = 36 | N = 14 |
 Patients with exacerbations, n (%) | 6 (20.0) | 12 (33.3) | 2 (14.3) |
 Eventsa | 6 | 24 | 2 |
 Total time at risk, years | 11.75 | 13.87 | 5.80 |
 Adjusted COPD exacerbation rate (SE)b | 0.45 (0.25) | 1.30 (0.46) | 0.29 (0.24) |